Revenue rose 14 percent YoY to Rs 4,016.6 crore.
Dr Reddy’s Laboratories has reported a 44 percent year-on-year jump in its Q4 FY19 net profit at Rs 434.4 crore. Revenue rose 14 percent YoY to Rs 4,016.6 crore.
Operating profit, or EBITDA, rose 52.7 percent at Rs 881.9 crore, while margin was up 22 percent versus 16.3 percent YoY.
The company's tax expense stood at Rs 150.7 crore as against Rs 72.6 crore YoY.
The Board has recommended a final dividend of Rs 20 (400 percent) per equity share of Rs 5 for FY19.At 15:06 hrs Dr Reddy’s Laboratories' shares was quoting at Rs 2,795.65, down Rs 8.85, or 0.32 percent, on the BSE.
Get Lok Sabha 2019 Live Election Results, constituency-wise tally, news, views and analysis
Follow our Lok Sabha Election Result Live Blog here.